Explore more publications!

Press Releases

The North/South Chamber Orchestra Performs Music by Five Women Composers on March 5 in New York City
RCP responds to NHS England update on the 10 Point Plan to improve resident doctors’ working lives

RCP responds to NHS England update on the 10 Point Plan to improve resident doctors’ working lives

Analysis reveals Poverty in UK has Worsened

Analysis reveals Poverty in UK has Worsened

CGTN: Beyond differences: Why the British PM calls long-awaited China trip a 'huge opportunity'
Citipost Mail Achieves Investors in People Platinum Following Exceptional Assessor Review
Business Reporter: Improving efficiency to build smoother customer journeys
Endeavour Silver Announces Q4 2025 Financial Results; Earnings Call at 10AM PST (1PM EST) Today
 Luware modernises SIX’s financial market communications with cloud-native efficiency and compliance
The Microalgae Industrial Cultivation System Market is projected to grow to USD 3.69 billion by 2030, CAGR of 15.8%.
Zscaler Announces Strong Second-Quarter Fiscal 2026 Results; Raises Fiscal 2026 ARR Guidance to 24%
Aura Signed the Agreement to Relocate Road at Borborema Mine, Unlocking an additional 670 Koz of gold in Mineral Reserves, totaling 1.5 Moz
Aura Announces Q4 2025 and FY 2025 Financial and Operational Results
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
saVRee Launches Maritime Training Courses to Build Digital Competency Across Marine and Offshore Operations
Aura Declares Dividend of US$0.66 Per Share and US$0.22 Per BDR Based on Q4 2025 Results, Resulting in a Dividend Yield of 6.2%¹  in the LTM
BizClik Returns With CPD-Accredited Procurement & Supply Chain LIVE and Sustainability LIVE: The Net Zero Summit
EpicQuest Education Enters into MOU to Offer its Masters in Management Program in the South Asia Market
Court minutes from 2023 that were previously redacted

Court minutes from 2023 that were previously redacted

FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions